# Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

> **NCT04735588** · — · UNKNOWN · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 140 (estimated)

## Conditions studied

- Immune Thrombocytopenia
- ITP
- Covid19
- ITP Secondary to Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04735588
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-22
- **Primary completion:** 2023-06
- **Final completion:** 2024-03
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04735588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04735588, "Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04735588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*